Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer

Summary: Castration-resistant prostate cancer (CRPC) presents a significant challenge in treatment following androgen deprivation therapy. This study evaluates Trillin, a compound with antioxidant and anti-inflammatory properties, for its therapeutic potential against CRPC. Using DU145 and PC3 cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanlong Wang, Yulin Peng, Wenjun Hao, Chengjian He, Xiang Gao, Peng Liang, Haolin Zhao, Ying Wang, Liang Wang, Zhenlong Yu, Zhiyu Liu
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224027329
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595786844602368
author Yanlong Wang
Yulin Peng
Wenjun Hao
Chengjian He
Xiang Gao
Peng Liang
Haolin Zhao
Ying Wang
Liang Wang
Zhenlong Yu
Zhiyu Liu
author_facet Yanlong Wang
Yulin Peng
Wenjun Hao
Chengjian He
Xiang Gao
Peng Liang
Haolin Zhao
Ying Wang
Liang Wang
Zhenlong Yu
Zhiyu Liu
author_sort Yanlong Wang
collection DOAJ
description Summary: Castration-resistant prostate cancer (CRPC) presents a significant challenge in treatment following androgen deprivation therapy. This study evaluates Trillin, a compound with antioxidant and anti-inflammatory properties, for its therapeutic potential against CRPC. Using DU145 and PC3 cell lines and a mouse xenograft model, we demonstrate that Trillin effectively inhibits CRPC cell viability, proliferation, migration, and invasion while promoting apoptosis and cell-cycle arrest. Mechanistic investigations reveal that Trillin disrupts NF-κB/COX-2 signaling by downregulating MAP3K11 and COX-2 and inhibiting the nuclear translocation of NF-κB subunits. Additionally, Trillin enhances the expression of miR-145-5p, further modulating pathways critical for CRPC progression. These findings suggest that Trillin may offer a promising alternative approach for targeting CRPC, highlighting its potential as a therapeutic agent to improve patient outcomes.
format Article
id doaj-art-ae018ba372d74b10862a6812cbd56abf
institution Kabale University
issn 2589-0042
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series iScience
spelling doaj-art-ae018ba372d74b10862a6812cbd56abf2025-01-18T05:05:03ZengElsevieriScience2589-00422025-02-01282111505Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancerYanlong Wang0Yulin Peng1Wenjun Hao2Chengjian He3Xiang Gao4Peng Liang5Haolin Zhao6Ying Wang7Liang Wang8Zhenlong Yu9Zhiyu Liu10Department of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaCollege of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, ChinaDepartment of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaCollege of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, ChinaDepartment of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaDepartment of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaDepartment of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaDepartment of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaDepartment of Urology, The Second Hospital of Dalian Medical University, Dalian 116023, ChinaCollege of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Corresponding authorDepartment of Urology, The Second Hospital of Dalian Medical University, Liaoning Provincial Key Laboratory of Urological Digital Precision Diagnosis and Treatment, Liaoning Engineering Research Center of Integrated Precision Diagnosis and Treatment Technology for Urological Cancer, Dalian Key Laboratory of Prostate Cancer Research, Dalian 116023, China; Corresponding authorSummary: Castration-resistant prostate cancer (CRPC) presents a significant challenge in treatment following androgen deprivation therapy. This study evaluates Trillin, a compound with antioxidant and anti-inflammatory properties, for its therapeutic potential against CRPC. Using DU145 and PC3 cell lines and a mouse xenograft model, we demonstrate that Trillin effectively inhibits CRPC cell viability, proliferation, migration, and invasion while promoting apoptosis and cell-cycle arrest. Mechanistic investigations reveal that Trillin disrupts NF-κB/COX-2 signaling by downregulating MAP3K11 and COX-2 and inhibiting the nuclear translocation of NF-κB subunits. Additionally, Trillin enhances the expression of miR-145-5p, further modulating pathways critical for CRPC progression. These findings suggest that Trillin may offer a promising alternative approach for targeting CRPC, highlighting its potential as a therapeutic agent to improve patient outcomes.http://www.sciencedirect.com/science/article/pii/S2589004224027329CancerCell biologyMolecular biology
spellingShingle Yanlong Wang
Yulin Peng
Wenjun Hao
Chengjian He
Xiang Gao
Peng Liang
Haolin Zhao
Ying Wang
Liang Wang
Zhenlong Yu
Zhiyu Liu
Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer
iScience
Cancer
Cell biology
Molecular biology
title Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer
title_full Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer
title_fullStr Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer
title_full_unstemmed Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer
title_short Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer
title_sort trillin inhibits map3k11 nf κb cox 2 signaling pathways through upregulation of mir 145 5p in castration resistant prostate cancer
topic Cancer
Cell biology
Molecular biology
url http://www.sciencedirect.com/science/article/pii/S2589004224027329
work_keys_str_mv AT yanlongwang trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT yulinpeng trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT wenjunhao trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT chengjianhe trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT xianggao trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT pengliang trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT haolinzhao trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT yingwang trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT liangwang trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT zhenlongyu trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer
AT zhiyuliu trillininhibitsmap3k11nfkbcox2signalingpathwaysthroughupregulationofmir1455pincastrationresistantprostatecancer